Fusion Pharmaceuticals
FUSN
$21.43
Share price
0.00%
Change (1 day)
367.90%
Change (1 year)
Categories
P/S ratio for Fusion Pharmaceuticals (FUSN)
P/S ratio as of May 2024 (TTM): 881
According to Fusion Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 881.449. At the end of 2023 the company had a P/S ratio of 336.
P/S ratio history for Fusion Pharmaceuticals from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 336 | 248.64% |
| 2022 | 96.5 | -22.61% |
| 2021 | 125 | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |